S-1: N2OFF Faces Going Concern Amidst Strategic Shifts & Capital Needs

N2OFF, Inc. reports continued operating losses and substantial doubt about its ability to continue as a going concern, while pursuing strategic shifts in agri-food tech and renewable energy, and seeking significant capital through equity agreements.

Summary

• N2OFF, Inc. (formerly Save Foods, Inc.) is focused on sustainable operations in agri-food tech (eco crop protection) and solar projects, operating through its Israeli subsidiary (Save Foods Ltd.) and Nevada wholly-owned subsidiary (NITO Renewable Energy, Inc.).
• The company has a history of operating losses, with an accumulated deficit of $34,553,000 as of December 31, 2024, and $35,746,000 as of March 31, 2025.
• Net loss for the year ended December 31, 2024, was $5,347,000, an improvement from $7,260,000 in 2023, but the net loss for the three months ended March 31, 2025, worsened to $1,257,000 from $822,000 in the same period of 2024.
• Revenue from product sales decreased by 20% to $210,000 in 2024 from $263,000 in 2023, mainly due to decreased sales in Mexico, but increased by 50% to $66,000 in Q1 2025 from $44,000 in Q1 2024 due to increased sales to a U.S. client.
• Cost of sales increased by 200% to $165,000 in 2024 from $55,000 in 2023, primarily due to inventory write-offs in South Africa and Turkey and a temporary malfunction at a U.S. client.
• Research and development expenses decreased significantly by 81% to $369,000 in 2024 from $1,938,000 in 2023, reflecting cost reduction measures and a shift to commercialization.
• Selling and marketing expenses decreased by 13% to $238,000 in 2024 from $272,000 in 2023, mainly due to personnel reduction.
• General and administrative expenses decreased by 33% to $3,758,000 in 2024 from $5,576,000 in 2023, driven by lower share-based compensation and salaries.
• The company sold its 60% owned subsidiary, NTWO OFF, to Yaaran Investments Ltd. for NIS 15,000 (approximately $4,000) on April 9, 2025.
• N2OFF is in the process of acquiring MitoCareX Bio Ltd., which would make MitoCareX a wholly-owned subsidiary, contingent on stockholder approval. N2OFF has provided MitoCareX with three loans totaling $750,000.
• The company has a 70% interest in a joint venture in Italy for two battery storage projects, committing to lend €2,300,000 (approximately $2,490,000) to the joint venture.
• N2OFF currently owns approximately 25% of Plantify Foods Inc., a Canadian public company whose Israeli subsidiary was severely impacted by the war in Israel, leading to insolvency proceedings and Plantify having no business activity and minimal liquidity.
• The company entered into a Purchase Agreement with YA II PN, Ltd. on May 12, 2025, for up to $3,000,000 in advances, and an amendment on July 25, 2025, for additional commitment shares and extended payment terms for promissory notes.
• N2OFF's common stock is listed on the Nasdaq Capital Market under the symbol NITO, with a closing price of $0.2440 per share on July 29, 2025, and is currently considered a penny stock.

Sentiment

Score: 3

Explanation: The company faces significant financial distress, evidenced by a history of operating losses, increasing accumulated deficit, and explicit 'going concern' doubt. While there are positive strategic shifts and some revenue growth in the most recent quarter, these are overshadowed by substantial capital needs, ongoing losses, and operational delays due to geopolitical conflicts. The stock is also trading as a penny stock with delisting risk. The overall outlook remains highly uncertain and precarious.

Positives

• Net loss decreased by 26% in 2024 compared to 2023, indicating some improvement in cost management.
• Revenue increased by 50% in Q1 2025 compared to Q1 2024, driven by increased sales to a U.S. client.
• Gross profit increased by 225% in Q1 2025 compared to Q1 2024, mainly due to a decrease in cost of sales.
• Significant reductions in Research and Development expenses (81% decrease in 2024) and General and Administrative expenses (33% decrease in 2024) reflect successful cost-cutting measures.
• The company has a strong intellectual property portfolio with 13 issued patents in the U.S., Europe, Israel, and South Africa, and 10 pending applications, covering compositions and methods for protecting edible matter and improving appearance.
• Save Foods' products offer multi-purpose solutions for both food safety and food waste reduction, simplifying crop treatment and potentially leading to cost savings for customers.
• The company's products are designed for seamless implementation without requiring special equipment, as they integrate with or replace existing packing line processes.
• Ingredients in Save Foods' products are recognized as GRAS by the FDA, and the solutions significantly reduce or eliminate the need for conventional fungicides, promoting occupational safety and environmental benefits.
• Successful commercial pilots have led to adoption of solutions by packing houses for avocados and bell peppers in Israel, and initial commercial application for avocados in Peru.
• PeroStar has shown significant potential in reducing imazalil usage by at least 50% in easy peelers and up to 75% in mangos, while extending shelf life.
• Received pre-harvest regulatory approval registration in California for FreshProtect in October 2023.
• Received approval to sell products in Peru (January 2022) and Brazil (February 2024) without further regulatory approvals, facilitating market expansion.

Negatives

• The company has a history of operating losses and expects to incur additional losses for the foreseeable future, with an accumulated deficit of $35,746,000 as of March 31, 2025.
• There is substantial doubt about the company's ability to continue as a going concern, as existing cash is projected to be sufficient only until the beginning of Q4 2025.
• Revenue decreased by 20% in 2024 compared to 2023, mainly due to decreased sales in Mexico.
• Cost of sales increased by 200% in 2024, primarily due to inventory write-offs in South Africa and Turkey and a temporary malfunction at a U.S. client.
• Gross profit decreased by 78% in 2024, largely due to the increase in cost of sales.
• Financing expenses increased significantly by 430% in 2024, mainly due to interest on a $1,500,000 promissory note.
• The net loss for the three months ended March 31, 2025, increased by 53% compared to the same period in 2024, primarily due to increased financing expenses related to changes in fair value of warrant liabilities and credit facility.
• The investment in Plantify Foods Inc. has essentially become a company with no business activity and minimal liquidity due to its subsidiary's factory being severely impacted by the war in Israel, leading to voluntary insolvency proceedings.
• The company's common stock is currently trading below $1.00 per share and is subject to Nasdaq's minimum bid price requirement, risking potential delisting.
• The company relies on a limited number of suppliers for key components, posing a risk of production, quality, or financial difficulties.
• The sales cycle for products is lengthy, requiring at least two seasons of testing without assurance of sales, impacting profitability and revenue generation.

Risks

• History of operating losses and expectation of future losses, leading to substantial doubt about the ability to continue as a going concern.
• Need to raise significant additional capital, which may not be obtainable on acceptable terms or at all, potentially requiring cessation of operations.
• Challenges in completing and integrating current and future acquisitions and joint ventures, which could disrupt business and adversely affect results.
• Limited operating history makes it difficult to evaluate business prospects and execute the business plan successfully.
• Lengthy customer testing periods (at least two seasons) without assurance of sales, impacting revenue and profitability.
• Products and technology require additional trials to prove efficacy against various pathogens, produce types, and climates, prolonging the sales cycle.
• Commercial success depends on market acceptance by packing houses and other industries, which is not guaranteed.
• Significant competition from companies developing alternative environmentally friendly solutions and established players in the post-harvest market.
• Inability to respond effectively to technological changes in the industry could reduce demand for products.
• Reliance on a limited number of suppliers for key components, risking production disruptions or increased costs.
• Difficulty in establishing sales, marketing, and distribution capabilities or successful third-party relationships.
• Challenges in rapidly establishing a global distributorship network.
• Early test results may not be indicative of future tests, and regulatory approvals are not assured.
• Products are highly regulated by governmental agencies, and failure to obtain or maintain approvals would adversely impact marketability.
• Inherent dangers in production and transportation of hydrogen peroxide and highly concentrated organic acids could cause disruptions and liabilities.
• Business and operations may be affected by unexpected events, including climate change conditions and natural disasters, impacting financial results.
• Conditions in the global economy, including inflation and recessionary pressures, may adversely affect business.
• Increased attention to environmental, social, and governance (ESG) matters and conservation measures may adversely impact business.
• Deterioration of employee relationships or departure of key employees could adversely affect business.
• Risks relating to portfolio concentration on a small number of products.
• Operating results may fluctuate, making them difficult to predict and potentially causing results to fall short of expectations.
• International expansion exposes the company to business, regulatory, political, operational, financial, and economic risks.
• Business depends on international transactions, exposing it to foreign currency exchange rate fluctuations.
• Inability to secure and maintain patent or other intellectual property protection could harm competitiveness.
• Inability to prevent unauthorized use or disclosure of proprietary trade secrets and know-how could harm competitiveness.
• Potential for patent and other intellectual property litigation, which could be costly and divert management attention.
• Claims challenging inventorship or ownership of patents and intellectual property.
• Claims that products infringe intellectual property rights of others, leading to unexpected costs or sales prevention.
• Failure to comply with laws and regulations could lead to regulatory actions and harm reputation.
• Regulatory reforms may adversely affect ability to sell products profitably.
• Regulatory and compliance changes may adversely impact Solterra's operations and joint venture value.
• Permitting and licensing delays may impact Solterra's project timelines and joint venture value.
• Fluctuations in electricity tariffs may impact Solterra's revenue and joint venture value.
• Supply chain and contractor disruptions may delay Solterra's projects and affect joint venture value.
• Equipment malfunctions and downtime may impact Solterra's operations and joint venture value.
• Intense competition in the renewable energy sector may affect Solterra's market share and joint venture value.
• Joint venture and partnership risks may affect Solterra's projects and joint venture value.
• Safety and operational risks may impact Solterra's business and joint venture value.
• Evolution of business strategy may not be successful and may require additional financing or increase operational costs.
• Conditions in Israel, including conflicts with Hamas and other parties, as well as political and economic instability, may adversely affect operations.
• Inability to enforce covenants not-to-compete under Israeli law.
• Difficulty in acquiring jurisdiction and enforcing liabilities against officers and directors based in Israel.
• Failure to comply with Nasdaq listing requirements could lead to delisting.
• Market price of common stock may be highly volatile.
• Sales of substantial number of shares by existing stockholders could cause share price to fall.
• Need for additional capital, and sale of additional shares or debt securities could result in dilution.
• Nevada law and corporate provisions could make a merger, tender offer, or proxy contest difficult.
• Potential for securities litigation, which is expensive and could divert management attention.
• If analysts cease publishing research or publish negative reports, stock price and trading volume could decline.
• No anticipation of paying cash dividends in the foreseeable future.
• Disruptions to information technology systems due to cyber-attacks or failure to upgrade systems.
• Failure to comply with anti-bribery, anti-corruption, and anti-money laundering laws.
• Increased costs and management time due to Nasdaq listing compliance and reporting requirements.
• Risks related to compliance with corporate governance laws and financial reporting standards.
• Ongoing conflict in Ukraine may result in market volatility.
• Failure to implement and maintain effective internal control over financial reporting.
• Sales of substantial amounts of common stock by the Selling Stockholder, or the perception of such sales, could result in dilution and adversely affect stock price.
• Uncertainty in predicting actual number of shares sold under SEPA or gross proceeds.
• Investors buying shares at different times will likely pay different prices and experience different dilution levels.

Future Outlook

The company expects to continue incurring losses and negative cash flows for the foreseeable future. Management believes existing capital resources will be sufficient to fund operations until the beginning of the fourth quarter of 2025, but plans to seek additional capital through debt, equity, or strategic partnerships to support growth. The company intends to focus on converting recently completed pilots into paying customers, expanding into high-value crops like berries, and increasing exports to Europe due to favorable regulations. Future plans include acquiring or licensing complementary products and technologies and expanding to additional geographies and crop varieties.

Management Comments

• Management believes that the dollar is the currency in the primary economic environment in which the Group operates.
• Management believes that its existing capital resources will be sufficient to support its operating plan through the beginning of the fourth quarter of 2025.
• Management plans to continue securing sufficient financing through the sale of additional equity securities or capital inflows from strategic partnerships.
• Management believes that the principal competitive factors in our industry include reputation, product quality, customer service and customer intimacy, product innovation, technical service, and value creation.
• Management believes that our proprietary blend of food acids provides protection to the treated produce and works in synergy with well-known fungicides and sanitizers.
• Management believes that our focus on natural product chemistries will allow us to continually drive lower costs, higher product gross margins and efficacy through longer shelf life and reduction of food waste.
• Management believes that our SF3HS and SF3H provide improved sanitization of bacteria (including E. coli, Salmonella and Listeria) while leaving no toxic residues on fruits and vegetables.
• Management believes that the rising demand for healthy food among the global population will trigger the markets growth in the forthcoming years.

Industry Context

The company operates in the agri-food tech and renewable energy sectors, both driven by sustainability trends. In agri-food tech, there's increasing global demand for healthy, safe, and pesticide-free food, driven by consumer awareness, retailer quality focus, and stricter regulations (e.g., FSMA, MRLs in Europe). The market for post-harvest solutions is fragmented but dominated by large players, creating competitive challenges. In renewable energy, particularly solar PV, the market is competitive with both large global and local companies. Italy's updated National Energy and Climate Plan (NECP) and incentives for battery storage projects present significant opportunities for solar energy development. The company's strategy aligns with these trends by offering eco-friendly solutions and investing in renewable energy, but faces challenges from established competitors and the need for market acceptance of new technologies.

Comparison to Industry Standards

• Save Foods' solutions aim to significantly reduce or eliminate the need for conventional fungicides (e.g., imazalil, thiabendazole) by at least 50%, and in some cases entirely, which is a key differentiator from traditional post-harvest treatments offered by major players like DECCO U.S. Post-Harvest, Inc., Bayer AG, Syngenta Crop Protection AG, Xeda International, John Bean Technologies, and Agrofresh.
• The company's products, such as SavePROTECT/PeroStar, are designed to work synergistically with low concentrations of peracetic acid (PAA), optimizing its efficacy and eliminating strong odors, which is an improvement over PAA-alone applications.
• SavePROTECT/PeroStar helps maintain wash water at a low stable pH, strengthening the effectiveness of PAA and fungicides, a benefit not explicitly highlighted by traditional PAA or chlorine-based sanitizers.
• SF3HS and SF3H products demonstrate more than 99.99999% (>7.51 Log10) reduction of Listeria monocytogenes in 30 seconds, and 99.99% to 99.9999% reduction of Listeria, Salmonella, and E. coli in 30 seconds, which is a significant advantage over competitors where the current minimum contact time available is 45 seconds.
• The company's solutions have shown a decay reduction in bell peppers compared to current industry standards, maintaining firmness and resulting in 20% more bell peppers available for sale after 28 days.
• Trials on raspberries showed an 80% reclamation of otherwise wasted produce, and strawberries showed an 85% waste reduction after 15 days, demonstrating superior shelf-life extension compared to typical handling.
• Blueberry experiments showed shelf-life extension by seven days, and mango trials demonstrated extended shelf life with no fungicide use, or reduced post-harvest decay to zero with low fungicide concentration, outperforming conventional methods.
• The non-toxicity of FreshProtect allows application up to the day of harvest (0-day pre-harvest interval), which is a critical advantage over many conventional pesticides that have longer pre-harvest intervals.
• The company's focus on non-toxic residues and GRAS-recognized ingredients aligns with and potentially exceeds the 'Safer Choice' label standards promoted by the EPA, and addresses increasing consumer demand for organic and pesticide-free foods, a trend that traditional chemical suppliers are struggling to meet.
• The company's ability to operate without requiring special equipment for application provides a cost-effective and seamless implementation advantage over solutions that might require significant capital expenditure for new machinery.

Management Changes

Corporate Governance

Legal Proceedings

• No pending legal proceedings to which the company is a party or in which any director, officer, or affiliate has a material adverse interest.
• A claim was filed by ECOLAB against the registration of European Patent No. 11825901.9, but the Opposition to European Patent concluded in the company's favor in December 2024, maintaining the patent.

Related Party Transactions

• Securities Exchange Agreement with Plantify Foods Inc. (March 31, 2023): Company issued 166,340 shares (19.99% pre-closing) to Plantify, and Plantify issued 150,022 common shares (19.99% pre-closing) to the Company. The Company also lent CAD 1,500,000 (approx. $1,124,000) to Plantify via a convertible debenture. Asaf Itzhaik and Israel Berenstein, company directors, are also directors of Plantify.
• Debt Settlement Agreement with Plantify (November 15, 2024): Plantify issued 2,420,848 common shares to the Company in full payment of CAD 2,053,000 (approx. $1,437,000) debt, increasing the Company's holding to approx. 65% temporarily, then reduced to approx. 25% after subsequent Plantify issuances.
• MitoCareX Agreement (February 25, 2025): Company to acquire MitoCareX Bio Ltd., making it a wholly-owned subsidiary. Consideration includes $700,000 cash payment to SciSparc and issuance of Common Stock equal to 40% of the Company's fully diluted capital stock to sellers (SciSparc, Alon Silberman, Ciro Leonardo Pierri). Alon Silberman, MitoCareX CEO, is the brother of Kfir Silberman, owner of Pure Capital (a 5% stockholder and lender to the Company). Amitay Weiss and Liat Sidi, company board members, also serve on SciSparc's board.
• MitoCareX Loans (December 22, 2024, March 12, 2025, May 22, 2025): Company lent an aggregate of $750,000 to MitoCareX, guaranteed by L.I.A. Pure Capital Ltd. (owned by Kfir Silberman).
• Solterra Transactions: Company acquired shares of Solterra Energy (November 27, 2024, and December 31, 2024) for NIS 801,000 (approx. $219,000). Amitay Weiss, a company director, also serves on Solterra Energy's board. Company entered a shareholders agreement (February 24, 2025) for a 70% interest in a joint venture for battery storage projects in Sicily, Italy, committing to lend €2,300,000 (approx. $2,490,000).
• Pure Capital Credit Facility (October 1, 2024): Company entered into a facility agreement with L.I.A. Pure Capital Ltd. for up to €6,000,000 (approx. $6,510,000). Company issued a five-year warrant to Pure Capital to purchase 1,850,000 shares of common stock. Kfir Silberman owns Pure Capital.
• Consulting Services to Pure Capital: From January 2, 2023, through July 2025, the Company issued 1,173,573 shares to Pure Capital for consulting services. An additional 14,286 shares are held by Kfir Silberman.
• Compensation to Executive Officers and Directors: David Palach (CEO) and Lital Barda (CFO) receive salaries, bonuses, and stock awards. Directors receive fees and stock awards. These include significant share-based compensation.

Stakeholder Impact

• **Shareholders:** Face significant dilution risk from ongoing and future equity raises (SEPA, private placements, warrants). The stock is a 'penny stock' with Nasdaq delisting risk, potentially impacting liquidity and value. Continued operating losses and 'going concern' doubt pose substantial investment risk. However, strategic shifts into renewable energy and continued development in agri-food tech could offer long-term growth potential if successful.
• **Employees:** The company has implemented cost reduction measures, including personnel reductions, which could impact employee morale and job security. Key employees are crucial for operations, and their departure is a risk. Share-based compensation plans aim to incentivize and retain talent.
• **Customers:** Benefit from eco-friendly, non-toxic, and effective post-harvest solutions that improve food safety, extend shelf life, and reduce chemical residues. The company's focus on converting pilots to paying customers indicates a commitment to customer satisfaction and long-term relationships. However, delays in product adoption or supply chain issues could impact customer access to solutions.
• **Suppliers:** The company relies on a limited number of suppliers for key components, which could create dependency and risk if suppliers face difficulties. The company's financial health could impact its ability to meet payment obligations to suppliers.
• **Creditors:** The company has significant debt, including promissory notes and credit facilities, and its 'going concern' status raises concerns about its ability to repay obligations. The loans are often secured by company assets or future proceeds, providing some protection to lenders, but the overall financial instability presents a risk.

Next Steps

• Obtain stockholder approval for the acquisition of MitoCareX Bio Ltd. at a special meeting on September 25, 2025.
• File a further amendment to the Registration Statement to declare it effective for the proposed sale of shares by the Selling Stockholder.
• Continue to access funds from the Standby Equity Purchase Agreement (SEPA II) with YA II PN, Ltd. by registering additional shares.
• Utilize the $3,000,000 advances from the new Purchase Agreement with YA II PN, Ltd. for general corporate purposes and working capital, and to repay outstanding promissory notes.
• Continue to convert completed pilots in Peru, Brazil, the United States, and Israel into full commercial applications.
• Focus on expanding activities to include various berries and other high-value crops.
• Increase focus on exports to Europe from countries like Peru and Brazil.
• Actively search for and acquire or license complementary products and technologies to enhance the product portfolio.
• Establish strategic partnerships with leading market players and expand the global distribution network.

Key Dates

Recommendation

The company presents an extremely high-risk investment profile. It has a persistent history of significant operating losses and an explicitly stated 'substantial doubt about its ability to continue as a going concern,' indicating severe financial instability. While strategic shifts into renewable energy and agri-food tech are noted, these are early-stage and highly speculative, with no clear path to sustained profitability. The company's reliance on continuous dilutive equity financing, coupled with its stock trading as a 'penny stock' and facing Nasdaq delisting risk, points to a highly unfavorable risk-reward scenario for investors. The recent increase in net loss in Q1 2025 further exacerbates concerns. Without a clear and immediate path to profitability and financial stability, the downside risk is substantial, making it an unsuitable investment for seasoned investors or institutions.

Keywords

Agri-food tech, Renewable energy, Solar PV projects, Food safety, Food waste reduction, Post-harvest treatments, Eco crop protection, N2O emissions, Nasdaq Capital Market, SEC filing, S-1 registration, Equity purchase agreement, Going concern, Intellectual property, Israel conflict impact, Penny stock